Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

Lactate & Acidity Modulation based CD8⁺ T Cell Activation Service

Online Inquiry
Background Services Workflow Advantages Customer Reviews FAQs Associated Services Contact Us

An immunosuppressive tumor microenvironment, impaired T cell function, and challenges in developing effective immunotherapies are significant hurdles in current research. Creative Biolabs provides a lactate and acidity modulation based CD8+ T cell activation service to overcome T cell exhaustion, enhance anti-tumor immunity, and improve immunotherapy outcomes, thereby accelerating your immunotherapy research.

The Impact of Lactate and Acidity on CD8+ T Cells

The success of immunotherapy, particularly T cell-based approaches, is frequently hampered by the unique metabolic landscape of the tumor microenvironment. Glycolytic tumors often produce high levels of lactic acid, which creates an acidic milieu known to suppress CD8+ T cell function, leading to T cell exhaustion and impaired anti-tumor responses. This acidic environment significantly compromises the efficacy of immunotherapies. However, recent research indicates a more nuanced role for lactate, with forms like sodium lactate potentially boosting stem-like CD8+ T cells, suggesting targeted modulation can unlock potent immune functions. Developing methods to precisely control lactate and acidity is crucial to revive T cell activity and improve therapeutic outcomes.

Fig.1 Lactylation in T-cell-mediated immunoactivation and immunosuppression. (OA Literature)Fig.1 Lactylation affects both T-cell-mediated immunoactivation and immunosuppression.1

Lactate and Acidity Modulation based CD8+ T Cell Activation Service at Creative Biolabs

Creative Biolabs provides a specialized service designed to enhance CD8+ T cell functionality by precisely modulating the lactate and acidity levels within their microenvironment. Our service follows a meticulous workflow, ensures top-tier quality control at every stage, and comes with a commitment to robust and reliable results. This service delivers improved T cell cytotoxicity, enhanced T cell persistence in challenging environments, and optimized strategies for your immunotherapy projects, providing critical pre-clinical validation data.

Workflow: End-to-End Service Process

Step 1: Project Consultation & Design

This initial phase involves in-depth discussions with our expert team to understand your specific research goals, target indications, and experimental context. We assess the feasibility of your project and collaboratively design a tailored experimental plan.

Required Starting Materials: To initiate this service, clients typically provide

  • Client-provided T cells: Such as Peripheral Blood Mononuclear Cells (PBMCs), Tumor-Infiltrating Lymphocytes (TILs), or engineered T cells (e.g., CAR-T cells).
  • Relevant antigens/peptides: For specific T cell activation, if antigen-specific responses are desired.
  • Tumor cell lines: For co-culture and cytotoxicity assays, mimicking the tumor microenvironment.
Step 2: T Cell Isolation & Characterization

High-quality CD8+ T cells are isolated from your provided samples using advanced cell separation techniques. These isolated cells undergo initial phenotypic and functional characterization to establish a baseline.

Step 3: Metabolic Microenvironment Engineering

We establish controlled in vitro or ex vivo conditions that precisely mimic the metabolic challenges of the tumor microenvironment. This involves culturing T cells in media with finely tuned lactate concentrations and pH levels, allowing for systematic investigation of their impact.

Step 4: CD8+ T Cell Activation & Reprogramming

In this critical step, specific modulators are applied to the CD8+ T cells within the engineered microenvironment. These modulators can include inhibitors of lactate transporters (e.g., MCTs), pH buffering agents, or metabolic enhancers aimed at reversing T cell exhaustion and boosting their effector functions.

Step 5: Functional Assessment & Validation

A comprehensive suite of assays is performed to evaluate the enhanced activity of the modulated CD8+ T cells. This includes assessing their ability to kill tumor cells, produce key cytokines, proliferate, and resist exhaustion. Metabolic flux analysis can also be performed to understand underlying changes.

Attractive Advantages

Overcomes T Cell Exhaustion

Directly addresses a critical barrier to effective immunotherapy by reversing the suppressive effects of the tumor microenvironment.

Enhances Anti-Tumor Efficacy

Leads to more potent and sustained anti-tumor immune responses, improving therapeutic potential.

Enables Rational Drug Design

Provides crucial insights for developing novel immunotherapeutic agents that target metabolic pathways.

Supports Target Validation

Offers a robust platform for validating metabolic targets and evaluating the efficacy of modulating agents.

Provides Precise Control

Allows for fine-tuned control over T cell activation conditions, enabling detailed mechanistic studies.

Customer Reviews

Breast cancer biomarkers at key points during disease progression
Enhanced Efficacy
Prof. Sn M*er. Superior Anti-Tumor Response!
Creative Biolabs' service provided us with a powerful tool to overcome T cell anergy. The ability to precisely control the metabolic microenvironment yielded superior anti-tumor responses compared to traditional activation methods, accelerating our pre-clinical validation.
April 2024 20 Likes
Breast cancer biomarkers at key points during disease progression
Precision Modulation
Dr. La A*on. Increased Cytokine Production!
Using Creative Biolabs' Lactate and Acidity Modulation based CD8+ T Cell Activation Service in our research has significantly improved/facilitated the in vitro cytokine production of our exhausted T cells, providing critical data for our lead candidate selection.
Aug 2024 20 Likes

FAQs

Q1: What types of T cells can be activated and modulated using this service?

A1: Our service is primarily focused on CD8+ T cells, given their critical role in anti-tumor immunity. However, we can adapt protocols for other T cell subsets or even engineered T cells (e.g., CAR-T, TCR-T cells) based on your specific project requirements. We encourage you to discuss your unique needs during the initial consultation.

Q2: How does this service compare to standard T cell activation methods?

A2: Unlike standard methods that primarily focus on antigenic stimulation, our service specifically addresses the metabolic dysfunction induced by the tumor microenvironment. By modulating lactate and acidity, we aim to reverse T cell exhaustion and enhance their intrinsic anti-tumor capabilities, providing a complementary and often superior approach for overcoming resistance mechanisms.

Q3: Can this service be customized for specific disease models or unique metabolic conditions?

A3: Absolutely. Our service is highly customizable. We can tailor the metabolic microenvironment (e.g., lactate concentrations, pH levels, glucose deprivation) to mimic specific disease contexts, such as different tumor types or inflammatory conditions. This allows for more physiologically relevant and translatable research outcomes.

Q4: What kind of data and readouts can I expect from this service?

A4: You will receive comprehensive data, including T cell viability and proliferation, cytokine production profiles, cytotoxicity assay results, and detailed flow cytometry analysis of activation and exhaustion markers. For an even deeper understanding, we can also offer metabolic flux analysis to monitor changes in T cell metabolism.

Q5: Are there any specific sample preparation requirements or precautions for providing cells for this service?

A5: We recommend providing fresh, viable T cell samples (e.g., PBMCs, TILs) transported under appropriate conditions. Our team will provide detailed guidelines for sample collection and shipment during the project consultation to ensure optimal cell quality and experimental success.

Associated Services

To achieve your comprehensive immunotherapy goals, Creative Biolabs offers a suite of complementary services:

Work with Creative Biolabs

At Creative Biolabs, our lactate and acidity modulation based CD8+ T cell activation service offers a crucial pathway to overcome T cell exhaustion and unleash potent anti-tumor immunity. Leveraging our deep scientific expertise and advanced platforms, we are dedicated to providing precise, data-driven solutions that accelerate your immunotherapy research and development. Please contact us for further details.

Reference

  1. Hao, Zhi-Nan et al. "Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy." Biomolecules vol. 14,12 1646. 21 Dec. 2024, doi:10.3390/biom14121646. Distributed under Open Access License CC BY 4.0, without modification.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.